Expression of epidermal and transforming growth factors in pancreatic cancer

Oncology Reports

Volumn 3, Issue 5, 1996, Pages 963-966

  Lakshmi Kesari, A ^a   Radhakrishnan, R ^a   Bhanumathi, A ^b   Ravi, D ^a   Srinivas, G ^a   Krishnan Nair, M ^a   Radhakrishna Pillai, M ^a,c  

^a Regional Cancer Center   (India)

^b Department of Surgery   (India)

^c REGIONAL CANCER CENTRE   (India)

Author keywords

EGF; pancreatic cancer; TGF

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; CHRONIC PANCREATITIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 0029788089     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.3.5.963     Document Type: Article

References (15)

1. Boring CC, Squires TS and Heath CW: Cancer Statistics, 1992. CA 42: 30-31, 1992.
2. Williamson RCN: Pancreatic cancer: the greatest oncological challenge. Br Med J 296: 445-446, 1991.
3. Abbruzzese JL: Novel diagnostic and therapeutic approaches to pancreatic cancer. Cancer Bull 46: 525-531, 1994.
4. DiMagno EP, Layer P and Clain JE: Chronic pancreatitis. In: The Exocrine Pancreas: Biology, Pathobiology and Diseases. WLW Go, EP DiMagno, JD Gardner, E Lebenthal, HA Reber and GA Scheele (eds). Raven Press, New York, pp665-706, 1993.
5. Oertel JE, Heffes CS and Oertel YC: Pancreas. In: Diagnostic Surgical Pathology. SS Sternberg (ed). Raven Press, New York, pp 1057-1093, 1989.
6. Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen JR, Dimagho EP, Sandberg AA and Domellof L: Pancreatitis and the risk of pancreatic cancer. N Engl J Med 328: 1433-1437, 1993.
7. American Joint Committee on Cancer. Manual for staging cancer. Third Edition. OH Beahrs, DE Henson, RVP Hutter and MH Myers (eds). JB Lippincot Company, New York, pp109-113, 1991.
8. Van den Berg FM, Baas IO, Polak MM and Offerhaus GJA: Detection of p53 overexpression in routinely fixed paraffin embedded tissue of human carcinomas using a novel target unmasking fluid. Am J Pathol 142: 381-385, 1993.
9. Chandran GJ, Balaram P, Kannan S, Pillai R, Nalinakumari KR and Nair MK: Immunohistochemical localization of epidermal growth factor and its receptor in normal, premalignant and malignant oral mucosa. Int J Oncol 4: 503-508, 1994.
10. Kannan S, Balaram P, Chandran GJ, Pillai R, Mathew B and Nair MK: Co-expression of ras p21 and epidermal growth factor receptor during various stages of tumor progression in oral mucosa. Tumor Biol 15: 73-81, 1994.
11. Sporn MB and Roberts AB: Autocrine growth factors and cancer. Nature 313: 745-747, 1985.
12. Lemoine NR, Hughes CM, Barton CM, Poulsom R, Jeffery RE, Kloppel G, Hall PA and Gullick WJ: The epidermal growth factor receptor in human pancreatic cancer. J Pathol 166: 7-12, 1992.
13. Friess H, Yamanaka Y, Buchler M, Kobrin MS, Tahara E and Korc M: Cripto, a member of the epidermal growth factor family is over-expressed in human pancreatic cancer and chronic pancreatitis. Int J Cancer 56: 668-674, 1994.
14. Chen YF, Pan GZ, Hou X, Liu TH, Yanaihara C and Yanaihara N: Epidermal growth factor and its receptors in human pancreatic carcinoma. Pancreas 5: 278-283, 1990.
15. Smith JJ, Derynck R and Korc M: Production of transforming growth factor α in human pancreatic cancer cells: evidence for a superagonist autocrine cycle. Proc Natl Acad Sci USA 84: 7567-7570, 1987.